Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Chemotherapy-induced Peripheral Neurotoxicity Using a Point-of-care Nerve Conduction Study Device

NCT04778878 is registered in ClinicalTrials.gov with Oulu University Hospital as lead sponsor.

NCT NCT04778878
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04778878 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Chemotherapy-induced Peripheral Neurotoxicity Using a Point-of-care Nerve Conduction Study Device
Lead sponsor
Oulu University Hospital
Phase
Observational
Overall status
Completed
Start date
October 1, 2019
Completion date
February 28, 2021
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer